Medicaid managed care organization service coverage and diagnosis and treatment of opioid use disorder: evidence from quasi-random auto-assignment in Kentucky
Open Access
- 11 June 2025
- journal article
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 3 (7)
Abstract
Introduction: Opioid-related mortality continues to claim tens of thousands of American lives annually. Medicaid plays an outsized role in financing opioid use disorder (OUD) treatment, paying for almost 40% of all Americans who received OUD treatment in 2017. Methods: Using Medicaid T-MSIS Analytic Files data and a novel data set of Medicaid managed care organization (MCO) plan coverage, we examined the relationship between comprehensiveness of benefits for OUD treatment provided by Medicaid MCO plans and the likelihood of OUD diagnosis and medications for OUD (MOUD) receipt among newly enrolled Medicaid beneficiaries in Kentucky. We use two stage least squares to adjust for MCO plan choice that may be correlated with individual OUD risk or individual demand for OUD treatment. Results: Our findings show that Medicaid beneficiaries assigned to MCO plans with more comprehensive OUD benefits are more likely to be diagnosed with OUD and to receive MOUD. Conclusion: These results suggest that increasing Medicaid MCO plan coverage to include a broader array of OUD treatment services and medications may be an effective strategy for increasing both OUD diagnosis and MOUD receipt, which is crucial for combating the ongoing opioid epidemic.Keywords
Funding Information
- National Institutes of Health
This publication has 14 references indexed in Scilit:
- Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021JAMA Network Open, 2023
- Opioid Use DisorderAnnals of Internal Medicine, 2022
- Association of the Frequency of In-Home Care Services Utilization and the Probability of In-Home DeathJAMA Network Open, 2021
- Retention Strategies for Medications for Addiction Treatment in Adults With Opioid Use Disorder: A Rapid Evidence Review2020
- Executive Summary of the Focused Update of the ASAM National Practice Guideline for the Treatment of Opioid Use DisorderJournal of Addiction Medicine, 2020
- Buprenorphine Treatment for Opioid Use Disorder: An OverviewCNS Drugs, 2019
- Buprenorphine Therapy for Opioid Use Disorder2018
- Medicaid program choice, inertia and adverse selectionJournal of Health Economics, 2017
- Two‐Stage Residual Inclusion Estimation in Health Services Research and Health EconomicsHealth Services Research, 2017
- Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid DependenceArchives of General Psychiatry, 2011